These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3895654)

  • 1. Cyclosporine: toxicity, metabolism, and drug interactions--implications from animal studies.
    Whiting PH; Thomson AW; Simpson JG
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):134-44. PubMed ID: 3895654
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental cyclosporine nephrotoxicity: risk of concomitant chemotherapy.
    Ryffel B; Müller AM; Mihatsch MJ
    Clin Nephrol; 1986; 25 Suppl 1():S121-5. PubMed ID: 3708922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine nephrotoxicity: studies in laboratory animals.
    Sullivan BA; Hak LJ; Finn WF
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):145-54. PubMed ID: 3895655
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal dysfunction in animal models of cyclosporine toxicity.
    Paller MS; Murray BM
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):155-9. PubMed ID: 3895656
    [No Abstract]   [Full Text] [Related]  

  • 5. The possible relationship between hepatic drug metabolism and ketoconazole enhancement of cyclosporine nephrotoxicity.
    Gumbleton M; Brown JE; Hawksworth G; Whiting PH
    Transplantation; 1985 Oct; 40(4):454-5. PubMed ID: 4049500
    [No Abstract]   [Full Text] [Related]  

  • 6. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug interactions with cyclosporine: implications from animal studies.
    Whiting PH; Burke MD; Thomson AW
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):56-70. PubMed ID: 3787717
    [No Abstract]   [Full Text] [Related]  

  • 8. Histopathology of cyclosporine.
    Wallace AC
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):117-22. PubMed ID: 3895653
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients.
    Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketoconazole inhibits cyclosporine metabolism in vivo in mice.
    Anderson JE; Blaschke TF
    J Pharmacol Exp Ther; 1986 Mar; 236(3):671-4. PubMed ID: 3950868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of blood levels and tissue levels of cyclosporine with the histologic features of cyclosporine toxicity.
    Kumar MS; White AG; Alex G; Antos MS; Philips EM; Abouna GM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):407-13. PubMed ID: 3363646
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug interactions with cyclosporine.
    Kerr LE
    Clin Pharm; 1984; 3(4):346, 348. PubMed ID: 6467874
    [No Abstract]   [Full Text] [Related]  

  • 14. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation.
    Savoldi S; Scolari F; Sandrini S; Scaini P; Sacchi G; Tardanico R; Camerini C; Salerni B; Tonini G; De Nobili U
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):777-84. PubMed ID: 3291313
    [No Abstract]   [Full Text] [Related]  

  • 17. Issues in the pathophysiology of nephrotoxic renal tubular cell injury pertinent to understanding cyclosporine nephrotoxicity.
    Weinberg JM
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):81-90. PubMed ID: 3895674
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine nephrotoxicity.
    Ryffel B; Mihatsch MJ
    Toxicol Pathol; 1986; 14(1):73-82. PubMed ID: 3520782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
    Chapman JR; Morris PJ
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.